Induction of cytotoxic T lymphocyte responses using anti-CD40 antibodies
US7172759B2 · kind B2 · utility
16Cited by
9References
6Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 1, 2001 |
| Grant date | Feb 6, 2007 |
| Priority date | — |
| Expiry date | Feb 1, 2021 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/31
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Disclosed are methods of inducing maturation of antigen presenting cells and cytotoxic T lymphocyte responses utilizing agonist anti-CD40 antibodies that do not block the binding of CD40L to CD40.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.